Covalon Technologies (OTCMKTS:CVALF) Trading 0.5% Higher – Still a Buy?

Covalon Technologies Ltd. (OTCMKTS:CVALF) shares rose 0.5% on Tuesday . The stock traded as high as $2.24 and last traded at $2.22. 22,853 shares changed hands during mid-day trading, an increase of 63% from the average daily volume of 14,008 shares. The stock had previously closed at $2.21.

Covalon Technologies Price Performance

The business’s 50 day moving average price is $2.32 and its 200-day moving average price is $1.63. The company has a market cap of $56.53 million, a P/E ratio of -24.94 and a beta of -0.36.

Covalon Technologies (OTCMKTS:CVALF) last released its earnings results on Wednesday, August 21st. The company reported $0.04 EPS for the quarter. The firm had revenue of $6.74 million during the quarter. Covalon Technologies had a negative net margin of 2.94% and a negative return on equity of 4.40%.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.